Purchase Order 75N93018P01366

Award Date 9/20/18
Potential Completion Date 12/14/18
Potential Value $201K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98115, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Diagenode, LLC, a for-profit limited liability company, to provide epigenomic sequencing services and bioinformatics analysis. The one-year contract, valued at $61,310.00, does not have a set-aside designation. The services will support the National Institute of Allergy and Infectious Diseases' research on variable penetrance...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $3,938.22 firm fixed price purchase order is for the delivery of sequencing kits, with a completion date of September 14, 2015. The contract has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $249,996 firm fixed price purchase order to Gene By Gene, LTD for clinical grade whole genome sequencing services. The contract calls for Gene By Gene to deliver these sequencing services from its Houston, Texas facility between September 1, 2023 and December 31, 2023 to support NIAID's research efforts in the areas of allergy and infectious disease. No...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $34,697.53 firm fixed price purchase order to Genscript USA Inc. to provide DNA services in support of vaccine development efforts. Under the contract, Genscript will deliver gene synthesis, VectorArk cloning, and express plasmid preparation services. These services will enable the creation of peptide and protein immunogens as well as DNA constructs containing...
This is a firm fixed-price purchase order contract awarded to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $50,955 contract is for subcloning, mutagenesis, and DNA preparation test services, and was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services' National Institutes of Health. The contract has an ultimate completion date of January 19, 2015 and was awarded on...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
The federal contract award is for the preparation and submission of genome data to GenBank, a genetic sequence database. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The prime contractor is IG Assets Inc., and the contract has a ceiling value of $6,000.00 with a firm fixed price. The contract does not have a set-aside designation. The award was made on June 7, 2011, with a completion date of July 25,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $145,590 purchase order to Clinical Research Sequencing Platform, LLC for clinical genome sequencing services. The prime contractor, Clinical Research Sequencing Platform, LLC, is a division of The Broad Institute, Inc. doing business as Broad Institute of MIT and Harvard. The firm fixed price contract runs from August 30, 2023 through December 31, 2023 to...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $488,023.29 delivery order contract to Medical Science & Computing, LLC, a for-profit limited liability company, to provide professional, scientific, and technical support services for the Division of Intramural Research/Laboratory of Malaria Immunology and Vaccinology (DIR/LMIV). The contract is a cost-plus-fixed-fee arrangement under the...

This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Scisco Genetics Inc., a for-profit organization, for DNA sequencing services to support NIAID's Malaria Infection Biology and Immunity Section research in malaria vaccine development. The contract is for the identification of alleles of several human leukocyte antigen (HLA) genes as well as killer-cell immunoglobulin-like receptor (KIR) genes using DNA samples from Mali. The contract is a firm-fixed-price purchase order with a potential value of $201,390.00 and a completion date of December 14, 2018. The contract was awarded on a sole-source basis under FAR Part 13.501(a)(1) as only one source was available to provide the unique services required. No set-aside was used for this procurement.

Generated 3/22/24, 11:27 PM